Twitter Linkedin
Subscribe

Hypex Bio initiates next phase of growth plan

Richard Roberts

‘The most important change we are seeing is that hydrogen-peroxide-based explosives are increasingly being discussed as a strategic alternative to the traditional ammonium-nitrate paradigm’

Hypex Bio founder Thomas Gustavsson says the company is looking to remove “remaining barriers to large-scale adoption” of its next-generation mine explosives to position itself for long-term growth as it pursues a significant equity financing.

InvestMETS.com understands the Swedish firm, which has South Africa’s Omnia Holdings as a circa-10% shareholder, is looking to raise up to €30 million to accelerate international commercialisation of its nitrate and ammonia-free explosives.

This content is available to Paid Subscribers only. If you are already a subscriber, login using the panel below or visit our Subscribe page to view subscription packages and/or Subscribe now.
Latest News

Not registered? Register Now

Partner Content
iStock-1130965935
Featured Research
techblue